Eikon Therapeutics Implements Second Major Staff Reduction in Under Two Years

Eikon Therapeutics announced a 15% reduction in its workforce in May 2025, marking the second major staff cut in less than two years123.

The company cited U.S. government funding cuts affecting academic institutions as the reason for the layoffs, which has forced the company to pause the development of advanced research instruments intended for external researchers23.

Previously, in October 2023, Eikon Therapeutics cut at least 10% of its staff4.

Eikon's recent staff reductions reflect broader biotech industry trends, with multiple companies including Eikon, Schrödinger, and others announcing layoffs in early 2025 to manage costs amid tighter funding environments3.

Sources:

1. https://firstwordpharma.com/story/5965140

2. https://opentools.ai/news/eikon-therapeutics-faces-strategic-revamp-amid-us-funding-cuts15percent-staff-laid-off

3. https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025

4. https://www.bizjournals.com/sanfrancisco/news/2023/10/09/layoffs-eikon-therapeutics-cancer-roger-perlmutter.html